These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 1894396)

  • 1. Comparative Chemical Profiling and Antimicrobial/Anticancer Evaluation of Extracts from Farmed versus Wild
    Varamogianni-Mamatsi D; Nunes MJ; Marques V; Anastasiou TI; Kagiampaki E; Vernadou E; Dailianis T; Kalogerakis N; Branco LC; Rodrigues CMP; Sobral RG; Gaudêncio SP; Mandalakis M
    Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine invertebrate natural products for anti-inflammatory and chronic diseases.
    Senthilkumar K; Kim SK
    Evid Based Complement Alternat Med; 2013; 2013():572859. PubMed ID: 24489586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral lead compounds from marine sponges.
    Sagar S; Kaur M; Minneman KP
    Mar Drugs; 2010 Oct; 8(10):2619-38. PubMed ID: 21116410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ aquaculture methods for Dysidea avara (Demospongiae, Porifera) in the northwestern Mediterranean.
    de Caralt S; Sánchez-Fontenla J; Uriz MJ; Wijffels RH
    Mar Drugs; 2010 May; 8(6):1731-42. PubMed ID: 20631865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marine compounds and their antiviral activities.
    Yasuhara-Bell J; Lu Y
    Antiviral Res; 2010 Jun; 86(3):231-40. PubMed ID: 20338196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 designed to use different tRNAGln isoacceptors prefers to select tRNAThr for replication.
    Li M; Eipers PG; Ni N; Morrow CD
    Virol J; 2006 Sep; 3():80. PubMed ID: 17002807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine sponges as pharmacy.
    Sipkema D; Franssen MC; Osinga R; Tramper J; Wijffels RH
    Mar Biotechnol (NY); 2005; 7(3):142-62. PubMed ID: 15776313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell biological aspects of HIV-1 infection: effect of the anti-HIV-1 agent Avarol.
    Müller WE; Schröder HC
    Int J Sports Med; 1991 Jun; 12 Suppl 1():S43-9. PubMed ID: 1894396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natural UAG suppressor glutamine tRNA in retrovirus infected cells].
    Kuchino Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):522-9. PubMed ID: 2539781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
    Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
    Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
    Liang C; Wainberg MA
    AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV-1 Tat transactivator protein: a therapeutic target?
    Fulcher AJ; Jans DA
    IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of formation of suppressor glutamine tRNA in Moloney murine leukemia virus-infected NIH-3T3 cells by Avarol.
    Kuchino Y; Nishimura S; Schröder HC; Rottmann M; Müller WE
    Virology; 1988 Aug; 165(2):518-26. PubMed ID: 2457280
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.